z-logo
open-access-imgOpen Access
Downregulation of the enhancer of zeste homolog 1 transcriptional factor predicts poor prognosis of triple-negative breast cancer patients
Author(s) -
Wei Peng,
Wei Tang,
JianDi Li,
RongQuan He,
JiaYuan Luo,
ZuXuan Chen,
JiangHui Zeng,
Xiaohua Hu,
JinCai Zhong,
Li Yang,
FuChao Ma,
Tianyi Xie,
SuNing Huang,
Lian-Ying Ge
Publication year - 2022
Publication title -
peerj
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.927
H-Index - 70
ISSN - 2167-8359
DOI - 10.7717/peerj.13708
Subject(s) - breast cancer , ezh2 , triple negative breast cancer , tissue microarray , cancer research , biology , oncology , proportional hazards model , downregulation and upregulation , microarray , cancer , gene expression , medicine , gene , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom